National Institute of Biology creates gene therapy spin-off

Ljubljana, 21 April - The National Institute of Biology (NIB) has licenced its gene therapy know-how and technology to a spin-off called Niba Labs, which will develop and commercialise technologies for the characterisation and quantification of therapeutic viruses used in gene therapy.